Related Experiment Video
Updated: May 18, 2026

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
Multiple left ventricular thrombi in a patient with left ventricular noncompaction
Cihan Cevik1, Nishant Shah, James M Wilson
1Department of Adult Cardiology, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas 77030, USA. ccevik@sleh.com
Insights
Myocardial noncompaction can lead to heart failure and blood clots. Even with aspirin, patients with severe noncompaction may need anticoagulation to prevent thromboembolic events.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Myocardial noncompaction is a rare congenital heart defect characterized by prominent trabeculae and deep intertrabecular recesses.
- Clinical manifestations include heart failure, arrhythmias, and thromboembolic events due to stagnant blood flow.
Observation:
- A 62-year-old woman with symptoms of heart failure due to left ventricular noncompaction presented with multiple left ventricular thrombi.
- These thrombi formed despite long-term aspirin therapy, highlighting a potential limitation of antiplatelet agents in this condition.
Findings:
- Left ventricular noncompaction is associated with an increased risk of thrombus formation.
- Severe left ventricular systolic dysfunction in noncompaction may necessitate anticoagulation beyond antiplatelet therapy.
Implications:
- Patients with myocardial noncompaction and risk factors for thromboembolism (e.g., atrial fibrillation, systemic embolism history, severe LV dysfunction) should be considered for anticoagulative therapy.
- Chronic antiplatelet therapy alone may be insufficient for preventing clot formation in specific patient subgroups with myocardial noncompaction.
Abstract:
The major clinical features of myocardial noncompaction are heart failure, arrhythmias, and thromboembolic events. Prominent myocardial trabeculae and deep recesses characteristic of myocardial noncompaction can cause stagnant blood flow and the formation of left ventricular clots. We describe the case of a 62-year-old woman who presented with symptoms of heart failure secondary to left ventricular noncompaction. Transthoracic and transesophageal echocardiography revealed multiple left ventricular thrombi, which had formed despite the patient's long-term therapy with aspirin. Anticoagulative therapy should be considered for patients with myocardial noncompaction who also have risk factors for thromboembolism, such as atrial fibrillation, a history of systemic embolism, or severe left ventricular systolic dysfunction. However, chronic antiplatelet therapy may not sufficiently prevent clot formation in patients who have myocardial noncompaction and severe left ventricular systolic dysfunction.
More Related Videos
Related Concept Videos
Cardiac Catheterization III: Left Heart Catheterization
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis I: Introduction

